$CHRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Coherus BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Coherus BioSciences, Inc.. Get notifications about new insider transactions in Coherus BioSciences, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2015 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | A | 29.00 | 150,000 | 4,350,000 | 150,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | A | 29.00 | 250,000 | 7,250,000 | 250,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 29.00 | 25,000 | 725,000 | 25,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 29.00 | 6,250 | 181,250 | 6,250 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Option Exercise | A | 29.00 | 50,000 | 1,450,000 | 50,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | A | 29.00 | 75,000 | 2,175,000 | 75,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 29.00 | 25,000 | 725,000 | 25,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 239,364 | 0 | 2,893,221 | 2.7 M to 2.9 M (+9.02 %) |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 96,098 | 0 | 2,653,857 | 2.6 M to 2.7 M (+3.76 %) |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 33 | 0 | 92 | 59 to 92 (+55.93 %) |
| Apr 03 2015 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | J | 0.00 | 12 | 0 | 59 | 47 to 59 (+25.53 %) |
| Apr 03 2015 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | A | 29.00 | 100,000 | 2,900,000 | 100,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 29.00 | 100,000 | 2,900,000 | 100,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Watler Peter K. | Chief Technical Off ... | Option Exercise | A | 29.00 | 100,000 | 2,900,000 | 100,000 | |
| Mar 18 2015 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Buy | J | 0.00 | 13 | 0 | 86,965 | 87 K to 87 K (+0.01 %) |
| Mar 18 2015 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Buy | J | 0.00 | 2,084 | 0 | 71,635 | 69.6 K to 71.6 K (+3.00 %) |
| Mar 18 2015 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Buy | J | 0.00 | 2,206 | 0 | 1,344,926 | 1.3 M to 1.3 M (+0.16 %) |
| Mar 12 2015 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Buy | J | 0.00 | 4 | 0 | 86,952 | 86.9 K to 87 K (0.00 %) |
| Mar 12 2015 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Buy | J | 0.00 | 828 | 0 | 69,551 | 68.7 K to 69.6 K (+1.20 %) |
| Mar 12 2015 | CHRS | Coherus BioScience ... | Lanfear Dennis M | President & CEO | Buy | J | 0.00 | 799 | 0 | 1,342,720 | 1.3 M to 1.3 M (+0.06 %) |
| Jan 02 2015 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 16.32 | 15,000 | 244,800 | 15,000 | |
| Jan 02 2015 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 16.32 | 15,000 | 244,800 | 15,000 | |
| Dec 24 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Buy | J | 0.00 | 114,639 | 0 | 709,482 | 594.8 K to 709.5 K (+19.27 %) |
| Dec 24 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Sell | J | 0.00 | 221,538 | 0 | 0 | 221.5 K to 0 (-100.00 %) |
| Dec 24 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Gift | G | 0.00 | 20,000 | 0 | 1,341,921 | 1.4 M to 1.3 M (-1.47 %) |
| Nov 14 2014 | CHRS | Coherus BioScience ... | KKR Biosimilar L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,499,499 | 0 | 0 | |
| Nov 14 2014 | CHRS | Coherus BioScience ... | KKR Biosimilar L.P. | 10% Owner | Buy | C | 0.00 | 2,499,499 | 0 | 2,499,499 | 0 to 2.5 M |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | C | 0.00 | 10,572 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | C | 0.00 | 43,011 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | C | 0.00 | 79,950 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | C | 0.00 | 514,893 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | C | 0.00 | 26,649 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Option Exercise | C | 0.00 | 194,889 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Buy | C | 0.00 | 10,572 | 0 | 53,583 | 43 K to 53.6 K (+24.58 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Buy | C | 0.00 | 43,011 | 0 | 43,011 | 0 to 43 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Buy | C | 0.00 | 79,950 | 0 | 594,843 | 514.9 K to 594.8 K (+15.53 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Buy | C | 0.00 | 514,893 | 0 | 514,893 | 0 to 514.9 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Buy | C | 0.00 | 26,649 | 0 | 221,538 | 194.9 K to 221.5 K (+13.67 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Wahlstrom Mats | Director | Buy | C | 0.00 | 194,889 | 0 | 194,889 | 0 to 194.9 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 149,970 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,846,890 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 47 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | P | 13.50 | 425,926 | 5,750,001 | 2,557,759 | 2.1 M to 2.6 M (+19.98 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | C | 0.00 | 149,970 | 0 | 2,131,833 | 2 M to 2.1 M (+7.57 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,846,890 | 0 | 1,981,863 | 135 K to 2 M (+1,368.34 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | HEALY JAMES | Director | Buy | C | 0.00 | 47 | 0 | 47 | 0 to 47 |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Daiichi Sankyo Company, LTD | Option Exercise | C | 0.00 | 2,867,426 | 0 | 0 | ||
| Nov 12 2014 | CHRS | Coherus BioScience ... | Daiichi Sankyo Company, LTD | Buy | C | 0.00 | 2,867,426 | 0 | 2,867,426 | 0 to 2.9 M | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | C | 0.00 | 2,624 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | C | 0.00 | 12,672 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | C | 0.00 | 39,991 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | J | 0.00 | 1 | 0 | 12,672 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | X | 0.00 | 429 | 0 | 12,673 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | X | 0.02 | 429 | 7 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Option Exercise | X | 1.67 | 26,505 | 44,184 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Buy | C | 0.00 | 2,624 | 0 | 78,836 | 76.2 K to 78.8 K (+3.44 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Buy | C | 0.00 | 12,672 | 0 | 76,212 | 63.5 K to 76.2 K (+19.94 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Buy | C | 0.00 | 39,991 | 0 | 63,540 | 23.5 K to 63.5 K (+169.82 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Sell | J | 0.00 | 2,956 | 0 | 23,549 | 26.5 K to 23.5 K (-11.15 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Richards Christos | Director | Buy | X | 1.67 | 26,505 | 44,184 | 26,505 | 0 to 26.5 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | C | 0.00 | 5,286 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | C | 0.00 | 21,527 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | C | 0.00 | 60,135 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | C | 0.00 | 3,193 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | C | 0.00 | 17,734 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | X | 0.00 | 3,225 | 0 | 17,734 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | X | 0.02 | 3,225 | 54 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | X | 0.00 | 19,976 | 0 | 60,135 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Option Exercise | X | 1.25 | 19,976 | 24,976 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Buy | C | 0.00 | 5,286 | 0 | 86,948 | 81.7 K to 86.9 K (+6.47 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Buy | C | 0.00 | 21,527 | 0 | 81,662 | 60.1 K to 81.7 K (+35.80 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Buy | C | 0.00 | 60,135 | 0 | 60,135 | 0 to 60.1 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Buy | C | 0.00 | 3,193 | 0 | 1,361,921 | 1.4 M to 1.4 M (+0.23 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Lanfear Dennis M | See Remarks | Buy | C | 0.00 | 17,734 | 0 | 68,723 | 51 K to 68.7 K (+34.78 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | C | 0.00 | 358,428 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | C | 0.00 | 266,502 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | C | 0.00 | 1,556,055 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | C | 0.00 | 319,935 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | X | 0.00 | 107,528 | 0 | 1,556,055 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | X | 0.02 | 107,528 | 1,796 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | C | 0.00 | 358,428 | 0 | 358,428 | 0 to 358.4 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | C | 0.00 | 266,502 | 0 | 2,142,492 | 1.9 M to 2.1 M (+14.21 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | C | 0.00 | 1,556,055 | 0 | 1,875,990 | 319.9 K to 1.9 M (+486.37 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | C | 0.00 | 319,935 | 0 | 319,935 | 0 to 319.9 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | C | 0.00 | 5,286 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Option Exercise | C | 0.00 | 21,505 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Buy | C | 0.00 | 5,286 | 0 | 26,791 | 21.5 K to 26.8 K (+24.58 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | FINCK BARBARA K | Chief Medical Offic ... | Buy | C | 0.00 | 21,505 | 0 | 21,505 | 0 to 21.5 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Option Exercise | C | 0.00 | 5,224 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Option Exercise | C | 0.00 | 39,991 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Option Exercise | C | 0.00 | 1,503 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Option Exercise | J | 0.00 | 2 | 0 | 1,503 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Option Exercise | X | 0.00 | 1,505 | 0 | 1,505 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Option Exercise | X | 0.02 | 1,505 | 25 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Option Exercise | X | 1.67 | 239,952 | 400,000 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Buy | C | 0.00 | 5,224 | 0 | 300,164 | 294.9 K to 300.2 K (+1.77 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Buy | C | 0.00 | 39,991 | 0 | 294,940 | 254.9 K to 294.9 K (+15.69 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Buy | C | 0.00 | 1,503 | 0 | 214,699 | 213.2 K to 214.7 K (+0.70 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Sell | J | 0.00 | 26,756 | 0 | 213,196 | 240 K to 213.2 K (-11.15 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Herman Alan C. | Chief Scientific Of ... | Buy | X | 1.67 | 239,952 | 400,000 | 239,952 | 0 to 240 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | LILLY ELI & CO | Option Exercise | C | 0.00 | 543,101 | 0 | 0 | ||
| Nov 12 2014 | CHRS | Coherus BioScience ... | LILLY ELI & CO | Option Exercise | C | 0.00 | 2,333,955 | 0 | 0 | ||
| Nov 12 2014 | CHRS | Coherus BioScience ... | LILLY ELI & CO | Buy | P | 13.50 | 164,963 | 2,227,001 | 3,042,019 | 2.9 M to 3 M (+5.73 %) | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | LILLY ELI & CO | Buy | C | 0.00 | 543,101 | 0 | 2,877,056 | 2.3 M to 2.9 M (+23.27 %) | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | LILLY ELI & CO | Buy | C | 0.00 | 2,333,955 | 0 | 2,333,955 | 0 to 2.3 M | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 13.50 | 134,973 | 1,822,136 | 134,973 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | LAWLIS V BRYAN | Director | Option Exercise | A | 13.50 | 14,997 | 202,460 | 14,997 | |
| Nov 10 2014 | CHRS | Coherus BioScience ... | Satvat Ali J. | Director | Option Exercise | A | 13.50 | 14,997 | 202,460 | 14,997 |